Sixera Pharma
PrivateLast Round
VC Round
Aug 8, 2017
Company Overview
Sixera Pharma operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a VC Round in August 2017.
Sixera Pharma is a biopharmaceutical company that develops treatments for rare skin diseases, with an initial focus on Netherton syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sixera Pharma Comparables
Compare Sixera Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ResVita Bio | 82% | |
| Dermelix Biotherapeutics | 82% | |
| Quoin Pharmaceuticals | 82% |
For institutional investors. Book with your work email.
Sixera Pharma Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Sixera Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flerie Invest | VC Round |
Sixera Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sixera Pharma's valuation, stock price, and market status.
Is Sixera Pharma a public or private company?
Sixera Pharma is a private company.
What is the current stock price of Sixera Pharma?
Sixera Pharma is a private company, so its shares have no public market price. Caplight tracks Sixera Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sixera Pharma worth (valuation)?
Valuation information for Sixera Pharma is not publicly available.
Can I buy Sixera Pharma stock?
Sixera Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sixera Pharma's last funding round?
Sixera Pharma's most recent funding round was VC Round on August 8, 2017.
Who are the main investors in Sixera Pharma?
Key investors in Sixera Pharma include Flerie Invest.
Will Sixera Pharma IPO soon?
No public IPO plans have been announced for Sixera Pharma.
How can I track Sixera Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Sixera Pharma's shares on secondary markets.